Polygenic risk score analyses of symptoms and treatment response in an antipsychotic-naive first episode of psychosis cohort

In this study, we aimed to test if the schizophrenia (SCZ) polygenic risk score (PRS) was associated with clinical symptoms in (a) the first episode of psychosis pre-treatment (FEP), (b) at nine weeks after initiation of risperidone treatment (FEP-9W) and (c) with the response to risperidone. We per...

詳細記述

保存先:
書誌詳細
出版年:Transl Psychiatry
主要な著者: Santoro, Marcos Leite, Ota, Vanessa, de Jong, Simone, Noto, Cristiano, Spindola, Leticia M., Talarico, Fernanda, Gouvea, Eduardo, Lee, Sang Hyuck, Moretti, Patricia, Curtis, Charles, Patel, Hamel, Newhouse, Stephen, Carvalho, Carolina Muniz, Gadelha, Ary, Cordeiro, Quirino, Bressan, Rodrigo Affonseca, Belangero, Sintia Iole, Breen, Gerome
フォーマット: Artigo
言語:Inglês
出版事項: Nature Publishing Group UK 2018
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6119191/
https://ncbi.nlm.nih.gov/pubmed/30171181
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41398-018-0230-7
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料